Connection

Evangelos Terpos to Receptor Activator of Nuclear Factor-kappa B

This is a "connection" page, showing publications Evangelos Terpos has written about Receptor Activator of Nuclear Factor-kappa B.
  1. Controversies in the use of new bone-modifying therapies in multiple myeloma. Br J Haematol. 2021 Jun; 193(6):1034-1043.
    View in: PubMed
    Score: 0.901
  2. Significance of macrophage inflammatory protein-1 alpha (MIP-1alpha) in multiple myeloma. Leuk Lymphoma. 2005 Dec; 46(12):1699-707.
    View in: PubMed
    Score: 0.080
  3. Soluble receptor activator of nuclear factor kappaB ligand-osteoprotegerin ratio predicts survival in multiple myeloma: proposal for a novel prognostic index. Blood. 2003 Aug 01; 102(3):1064-9.
    View in: PubMed
    Score: 0.066
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.